Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
In 55 patients with acute or subacute CVD a beneficial but dose dependent effect of PO on human blood rheologic properties has been demonstrated, indicated by a lowering of blood viscosity, a decrease of fibrinogen concentration and inhibition of PA.